Notably, some combinations, such as MYC overexpression + Trp53 alteration, which induced HCC in some but not all previously published models12,18, had very low to no tumour penetrance using our clonal evolution approach and did not reach end-stage tumours within the observed period. The gene discussed is MYC; the disease is neoplasm.